Fig. 6: Assessing treatment response through comparative miRNA profiling before and after NSCLC therapy. | British Journal of Cancer

Fig. 6: Assessing treatment response through comparative miRNA profiling before and after NSCLC therapy.

From: Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC)

Fig. 6

a Clinical profiles of patients treated with various therapies (n = 10) (CR: Complete Response, blue; PR partial response, yellow; and PD progressive disease, red) in the second blood withdrawal. b Changes in DE miRNA expression alteration between pre-treatment and post-treatment samples. c Heatmap of 17 differentially expressed miRNAs in five LUAD patients. d Heatmap of 28 differentially expressed miRNAs in five LUSC patients.

Back to article page